NDRC Issued Opinions and Notice on Drug Price Reform

Published date11 June 2015
Law FirmSheppard Mullin Richter & Hampton LLP
AuthorXiaolu Xu
Subject MatterChina,Drug Pricing,Health Insurance,Healthcare Reform,NDRC,Pharmaceutical Manufacturers,Pharmaceutical Patents,Prescription Drug Coverage,Prescription Drugs,Transparency

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT